A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE
Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to give patients who have had 4 or more prior lines of therapy
for multiple myeloma access to VELCADE. The study is for patients who are not eligible for
other clinical trials with VELCADE and for who VELCADE would otherwise not be available.